Analysis of the adequacy of preparation for end-stage renal disease care in Michigan

被引:0
|
作者
机构
来源
ASAIO J | / 3卷 / M422期
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Lipids in end-stage renal disease
    Wanner, C
    JOURNAL OF NEPHROLOGY, 2002, 15 (02) : 202 - 204
  • [32] Osteoporosis in end-stage renal disease
    Lindberg, JS
    Moe, SM
    SEMINARS IN NEPHROLOGY, 1999, 19 (02) : 115 - 122
  • [33] Keloids and end-stage renal disease
    Freedman, BI
    Morrow, MA
    Tuttle, AB
    Igwemezie, BM
    Rich, SS
    Sherertz, EF
    Tuttlea, FNAJANAEB
    NEPHRON, 1998, 80 (02): : 244 - 246
  • [34] Adiponectin and end-stage renal disease
    Markaki, Anastasia
    Psylinakis, Emmanuel
    Spyridaki, Aspasia
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2016, 15 (03): : 345 - 354
  • [35] Hypertension in end-stage renal disease
    Martínez-Maldonado, M
    KIDNEY INTERNATIONAL, 1998, 54 : S67 - S72
  • [36] End-Stage Renal Disease and Pregnancy
    Nadeau-Fredette, Annie-Claire
    Hladunewich, Michelle
    Hui, Dini
    Keunen, Johannes
    Chan, Christopher T.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2013, 20 (03) : 246 - 252
  • [37] Pregnancy and End-Stage Renal Disease
    Tangren, Jessica
    Nadel, Molly
    Hladunewich, Michelle A.
    BLOOD PURIFICATION, 2018, 45 (1-3) : 194 - 200
  • [38] Adiponectin and end-stage renal disease
    Markaki A.
    Psylinakis E.
    Spyridaki A.
    Hormones, 2016, 15 (3) : 345 - 354
  • [39] Pharmacotherapy of end-stage renal disease
    Schmid, Holger
    Schiffl, Helmut
    Lederer, Stephan R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 597 - 613
  • [40] Silicosis and end-stage renal disease
    Steenland, K
    Rosenman, K
    Socie, E
    Valiante, D
    SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH, 2002, 28 (06) : 439 - 442